Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
- Oktober -
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
Oktober 2016 - 76 products
CI
Selomida Gelenke
7.5 g
PR
PR
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
L
IP
CI
Ezetimib Zentiva 10mg
28
17.25
35.15
10 %
Tablets: Ezetimibum 10 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Ezetimib Zentiva 10mg
98
60.27
81.95
10 %
Tablets: Ezetimibum 10 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
V/S
Cuvitru 200 mg/ml
5 ml
65.42
87.55
10 %
Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
Cuvitru 200 mg/ml
10 ml
130.84
158.70
10 %
Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
Cuvitru 200 mg/ml
20 ml
261.68
301.00
10 %
Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
Cuvitru 200 mg/ml
40 ml
523.36
585.60
10 %
Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
V/S
Cuvitru 200 mg/ml
50 ml
654.20
727.90
10 %
Injection solution: Immunoglobulinum Humanum Normale 200 mg/ml
Takeda Pharma AG
B / SL
FB
G
L
IP
PP
Alprolix 250 IE
Set(s)
317.54
366.85
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 250 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 500 IE
Set(s)
635.08
692.65
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 500 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 1000 IE
Set(s)
1270.16
1344.20
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 1000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 2000 IE
Set(s)
2540.31
2647.40
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 2000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 3000 IE
3810.47
3950.60
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 3000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
CI
PP
Briviact 10 mg
14
30.58
49.65
10 %
Coated tablets: Brivaracetamum 10 mg
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
PP
Briviact 25 mg
56
118.62
145.40
10 %
Coated tablets: Brivaracetamum 25 mg
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
PP
Briviact 50 mg
56
118.62
145.40
10 %
Coated tablets: Brivaracetamum 50 mg
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
PP
Briviact 75 mg
56
118.62
145.40
10 %
Coated tablets: Brivaracetamum 75 mg
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
PP
Briviact 100 mg
56
118.62
145.40
10 %
Coated tablets: Brivaracetamum 100 mg
UCB-Pharma SA
B / SL
FB
G
IP
CI
Deanxit 0.5 mg/10 mg
30
2.89
12.40
10 %
Coated tablets: 2 Active Agents
Lundbeck (Schweiz) AG
B / SL
FB
G
IP
CI
Deanxit 0.5 mg/10 mg
100
7.92
17.85
10 %
Coated tablets: 2 Active Agents
Lundbeck (Schweiz) AG
B / SL
FB
G
L
IP
CI
PP
Galafold 123 mg
14
17664.59
18431.65
10 %
Capsules: Migalastatum 123 mg
Amicus Therapeutics
Switzerland GmbH
B / SL
FB
G
L
IP
CI
PP
Briviact 10 mg/ml
300 ml
145.34
174.50
10 %
Solution (oral): Brivaracetamum 50mg / 5ml
UCB-Pharma SA
B / SL
FB
G
L
IP
CI
Movicol Trinkfertig
20
7.66
17.55
10 %
Solution (oral): 4 Active Agents
Norgine AG
B / SL
FB
G
L
IP
CI
Enstilar
60 g
46.67
66.55
10 %
Schaum zur Anwendung auf der Haut: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL
FB
G
L
IP
CI
Nordimet 7.5 mg/0.3 ml
Fertigspritze(n)
11.43
28.95
10 %
Injection solution in prefilled syringe: Methotrexatum 7.5mg / 0.3ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 10.0 mg/0.4 ml
Fertigspritze(n)
14.10
31.80
10 %
Injection solution in prefilled syringe: Methotrexatum 10mg / 0.4ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 12.5 mg/0.5 ml
Fertigspritze(n)
15.58
33.40
10 %
Injection solution in prefilled syringe: Methotrexatum 12.5mg / 0.5ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 15.0 mg/0.6 ml
Fertigspritze(n)
16.26
34.15
10 %
Injection solution in prefilled syringe: Methotrexatum 15mg / 0.6ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 20.0 mg/0.8 ml
Fertigspritze(n)
18.21
36.25
10 %
Injection solution in prefilled syringe: Methotrexatum 20mg / 0.8ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 22.5 mg/0.9 ml
Fertigspritze(n)
19.37
37.55
10 %
Injection solution in prefilled syringe: Methotrexatum 22.5mg / 0.9ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 25 mg/1.0 ml
Fertigspritze(n)
20.53
38.80
10 %
Injection solution in prefilled syringe: Methotrexatum 25 mg/ml
Nordic Pharma GmbH
A / SL
FB
G
L
IP
CI
Nordimet 17.5 mg/0.7 ml
Fertigspritze(n)
17.70
35.70
10 %
Injection solution in prefilled syringe: Methotrexatum 17.5mg / 0.7ml
Nordic Pharma GmbH
A / SL
FB
G
IP
PP
Briviact 50 mg/5 ml
10
PR
PR
k.A.
Injection solution: Brivaracetamum 50 mg
UCB-Pharma SA
B
FB
G
IP
SWAN-Cholin 222 MBq/ml
222 MBq
PR
PR
k.A.
Injection solution: Fluorocholinum(18-f) 222 MBq/ml
SWAN Isotopen AG SWAN
Haus, Inselspital
A
FB
G
IP
CI
PP
Briviact 25 mg
14 x 1
PR
PR
k.A.
Coated tablets: Brivaracetamum 25 mg
UCB-Pharma SA
B
FB
G
IP
CI
PP
Briviact 50 mg
14 x 1
PR
PR
k.A.
Coated tablets: Brivaracetamum 50 mg
UCB-Pharma SA
B
FB
G
IP
CI
PP
Briviact 75 mg
14 x 1
PR
PR
k.A.
Coated tablets: Brivaracetamum 75 mg
UCB-Pharma SA
B
FB
G
IP
CI
PP
Briviact 100 mg
14 x 1
PR
PR
k.A.
Coated tablets: Brivaracetamum 100 mg
UCB-Pharma SA
B
FB
G
IP
CI
CM
Gerti Gynial 2 mg/30 mcg
21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Gerti Gynial 2 mg/30 mcg
3 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Gerti Gynial 2 mg/30 mcg
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Mizzi Gynial
21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Mizzi Gynial
3 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Mizzi Gynial
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B
FB
G
IP
CI
CM
Soffi Gynial 0.02 mg/0.10 mg
21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Soffi Gynial 0.02 mg/0.10 mg
3 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
CM
Soffi Gynial 0.02 mg/0.10 mg
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Zenzi Gynial 0.075 mg
28
PR
PR
k.A.
Coated tablets: Desogestrelum
Gynial AG
B
FB
G
IP
CI
Zenzi Gynial 0.075 mg
3 x 28
PR
PR
k.A.
Coated tablets: Desogestrelum
Gynial AG
B
FB
G
IP
CI
Zenzi Gynial 0.075 mg
6 x 28
PR
PR
k.A.
Coated tablets: Desogestrelum
Gynial AG
B
FB
G
CI
Selomida Gelenke
30 x 7.5 g
PR
PR
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
IP
CI
Silvir 25 mg
4
PR
PR
k.A.
film orodispersibile: Sildenafilum 25 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 25 mg
8
PR
PR
k.A.
film orodispersibile: Sildenafilum 25 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 25 mg
12
PR
PR
k.A.
film orodispersibile: Sildenafilum 25 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 50 mg
4
PR
PR
k.A.
film orodispersibile: Sildenafilum 50 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 50 mg
8
PR
PR
k.A.
film orodispersibile: Sildenafilum 50 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 50 mg
12
PR
PR
k.A.
film orodispersibile: Sildenafilum 50 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 50 mg
24
PR
PR
k.A.
film orodispersibile: Sildenafilum 50 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 75 mg
4
PR
PR
k.A.
film orodispersibile: Sildenafilum 75 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 75 mg
8
PR
PR
k.A.
film orodispersibile: Sildenafilum 75 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 75 mg
12
PR
PR
k.A.
film orodispersibile: Sildenafilum 75 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 75 mg
24
PR
PR
k.A.
film orodispersibile: Sildenafilum 75 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 100 mg
4
PR
PR
k.A.
film orodispersibile: Sildenafilum 100 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 100 mg
8
PR
PR
k.A.
film orodispersibile: Sildenafilum 100 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 100 mg
12
PR
PR
k.A.
film orodispersibile: Sildenafilum 100 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Silvir 100 mg
24
PR
PR
k.A.
film orodispersibile: Sildenafilum 100 mg
IBSA Institut
Biochimique SA
B
FB
G
IP
CI
Vroni Gynial
21
PR
PR
k.A.
überzogene Tablette: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Vroni Gynial
3 x 21
PR
PR
k.A.
überzogene Tablette: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Nordimet 7.5 mg/0.3 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 7.5mg / 0.3ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 10.0 mg/0.4 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 10mg / 0.4ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 12.5 mg/0.5 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 12.5mg / 0.5ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 15.0 mg/0.6 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 15mg / 0.6ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 20.0 mg/0.8 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 20mg / 0.8ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 22.5 mg/0.9 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 22.5mg / 0.9ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 25 mg/1.0 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 25 mg/ml
Nordic Pharma GmbH
A
FB
G
IP
CI
Nordimet 17.5 mg/0.7 ml
4 Fertigspritze(n)
PR
PR
k.A.
Injection solution in prefilled syringe: Methotrexatum 17.5mg / 0.7ml
Nordic Pharma GmbH
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home